Last reviewed · How we verify
ibuprofen, latanoprost, brimonidine
ibuprofen, latanoprost, brimonidine is a Small molecule drug developed by Philadelphia Eye Associates. It is currently in Phase 1 development. Also known as: placebo.
At a glance
| Generic name | ibuprofen, latanoprost, brimonidine |
|---|---|
| Also known as | placebo |
| Sponsor | Philadelphia Eye Associates |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ibuprofen, latanoprost, brimonidine CI brief — competitive landscape report
- ibuprofen, latanoprost, brimonidine updates RSS · CI watch RSS
- Philadelphia Eye Associates portfolio CI
Frequently asked questions about ibuprofen, latanoprost, brimonidine
What is ibuprofen, latanoprost, brimonidine?
ibuprofen, latanoprost, brimonidine is a Small molecule drug developed by Philadelphia Eye Associates.
Who makes ibuprofen, latanoprost, brimonidine?
ibuprofen, latanoprost, brimonidine is developed by Philadelphia Eye Associates (see full Philadelphia Eye Associates pipeline at /company/philadelphia-eye-associates).
Is ibuprofen, latanoprost, brimonidine also known as anything else?
ibuprofen, latanoprost, brimonidine is also known as placebo.
What development phase is ibuprofen, latanoprost, brimonidine in?
ibuprofen, latanoprost, brimonidine is in Phase 1.
Related
- Manufacturer: Philadelphia Eye Associates — full pipeline
- Also known as: placebo
- Compare: ibuprofen, latanoprost, brimonidine vs similar drugs
- Pricing: ibuprofen, latanoprost, brimonidine cost, discount & access